AJP - Endo Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 286: E718-E724, 2004; doi:10.1152/ajpendo.00358.2003
0193-1849/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (15)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davidoff, A. J.
Right arrow Articles by Ren, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davidoff, A. J.
Right arrow Articles by Ren, J.

Sucrose-induced cardiomyocyte dysfunction is both preventable and reversible with clinically relevant treatments

Amy J. Davidoff,1 Meredith M. Mason,1 Michael B. Davidson,1 Marybeth W. Carmody,1 Kadon K. Hintz,2 Loren E. Wold,2 Deborah A. Podolin,1 and Jun Ren2,3

1Department of Pharmacology, College of Osteopathic Medicine, University of New England, Biddeford, Maine 04005; 2Department of Pharmacology, Physiology and Therapeutics, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota 58203; and 3Division of Pharmaceutical Sciences, University of Wyoming College of Health Sciences, Laramie, Wyoming 82071

Submitted 7 August 2003 ; accepted in final form 2 January 2004

We recently identified cardiomyocyte dysfunction in the early stage of type 2 diabetes (i.e., diet-induced insulin resistance). The present investigation was designed to determine whether a variety of clinically relevant interventions are sufficient to prevent and reverse cardiomyocyte dysfunction in sucrose (SU)-fed insulin-resistant rats. Subsets of animals were allowed to exercise (free access to wheel attached to cage) or were treated with bezafibrate in drinking water to determine whether these interventions would prevent the adverse effects of SU feeding on cardiomyocyte function. After 6–8 wk on diet and treatment, animals were surgically prepared to assess whole body insulin sensitivity (intravenous glucose tolerance test), and isolated ventricular myocyte mechanics were evaluated (video edge recording). SU feeding produced hyperinsulinemia and hypertriglyceridemia, with euglycemia, and induced characteristic whole body insulin resistance. Both exercise and bezafibrate treatment prevented these metabolic abnormalities. Ventricular myocyte shortening and relengthening were slower in SU-fed rats (42–63%) compared with starch (ST)-fed controls, and exercise or bezafibrate completely prevented cardiomyocyte dysfunction in SU-fed rats. In separate cohorts of animals, after 5 wk of SU feeding, animals were either switched back to an ST diet or given menhaden oil for an additional 7–9 wk to determine whether the cardiomyocyte dysfunction was reversible. Both interventions have previously been shown to have favorable metabolic effects, and both improved myocyte mechanics, but only the ST diet reversed all indications of cardiomyocyte dysfunction induced by SU feeding. Thus phenotypic changes in cardiomyocyte mechanics associated with early stages of type 2 diabetes were found to be both preventable and reversible with clinically relevant treatments, suggesting that the cellular processes contributing to this dysfunction are modifiable.

type 2 diabetes; fish oil; exercise; fibrates



Address for reprint requests and other correspondence: A. J. Davidoff, Univ. of New England, College of Osteopathic Medicine, 11 Hills Beach Rd., Biddeford, ME 04005 (E-mail: adavidoff{at}une.edu).




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
R. M. Witteles and M. B. Fowler
Insulin-Resistant Cardiomyopathy: Clinical Evidence, Mechanisms, and Treatment Options
J. Am. Coll. Cardiol., January 15, 2008; 51(2): 93 - 102.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
R. Loganathan, M. Bilgen, B. Al-Hafez, S. V. Zhero, M. D. Alenezy, and I. V. Smirnova
Exercise training improves cardiac performance in diabetes: in vivo demonstration with quantitative cine-MRI analyses
J Appl Physiol, February 1, 2007; 102(2): 665 - 672.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
Z. Vasanji, E. J. F. Cantor, D. Juric, M. Moyen, and T. Netticadan
Alterations in cardiac contractile performance and sarcoplasmic reticulum function in sucrose-fed rats is associated with insulin resistance
Am J Physiol Cell Physiol, October 1, 2006; 291(4): C772 - C780.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.